Australia's Control Bionics rises on upbeat revenue

Control Bionics

13/06/2025 03:56

** Shares of Control Bionics CBL.AX rise 3.3% to A$0.031; set for best day since June 6, if gains hold

** The medical device maker says YTD unaudited revenue as at May 31 up 14% compared to same period last year

** Adds FY25 revenue on track to be a record year

** Co posted FY24 revenue of A$5.4 million ($3.5 million)

** Stock down 48.3% YTD, including moves in current session

($1 = 1.5434 Australian dollars)

(Reporting by Jasmeen Ara Shaikh in Bengaluru)

((JasmeenAraIslam.Shaikh@thomsonreuters.com;))